AcelRx Pharma Meets Expectations, But Says It Won't Submit New Zalviso Application

By: via Benzinga
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) extended its losses in after-hours trading Monday after the company said it won't ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.